Diseases, Conditions, Syndromes

Improving glycemic control may also aid COVID-19 outcomes

(HealthDay)—Insulin infusion helps achieve glycemic targets and may reduce the risk for poor outcomes in patients with hyperglycemia and COVID-19, according to a study published online May 19 in Diabetes Care.

Health

New Medicare benefit would limit insulin copays to $35 a month

Reacting to skyrocketing prices for insulin, the Trump Administration announced on Tuesday a new benefit that would limit Medicare recipients' copays for insulin to a maximum of $35 a month and save them about $446 a year ...

Diseases, Conditions, Syndromes

Age, CRP up risk for mortality in diabetes with COVID-19

(HealthDay)—For patients with diabetes and COVID-19, risk factors for mortality include older age and elevated C-reactive protein, and insulin usage is associated with poor prognosis, according to a study published online ...

page 2 from 100